Lurasidone/Cycloserine

鲁拉西酮/环丝氨酸

Report date: 2026/05/06 20:02:28

Base Information

Drug NameLurasidone/Cycloserine
Drug Alias NameLurasidone Hydrochloride/Cycloserine盐酸鲁拉西酮/环丝氨酸D-cycloserine/lurasidoneCycluradNRX-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonistsD-alanine--D-alanine ligase A inhibitorsDopamine D2 receptor antagonists +[6] 
TargetsSerotonin 7 (5-HT7) receptorSerotonin 2a (5-HT2a) receptorD-alanine--D-alanine ligase A +[6] 
Therapy Area/IndicationsDepressive Disorder, Treatment-ResistantDepressive Disorder, MajorBipolar Disorder +[14] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsYes CycloserineLurasidone Hydrochloride
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesAvineuroNeurorx
China Registration ClassN/A

Develop Information

Active CompaniesNRx Pharmaceuticals IncUniversity Of CalgaryAlvogen Inc +[6] 
Inactive CompaniesNorthwestern University
Active IndicationsDepressive Disorder, Treatment-ResistantDepressive Disorder, MajorBipolar Disorder +[13] 
Inactive IndicationsLow Back Pain

Other Information

ATC CodeN/A
Related LinksN/A